Final Guidance Sets Date For Mandatory De Novo Electronic Submissions

The Food and Drug Administration’s final guidance outlines the agency’s thinking for sponsors submitting de novo requests electronically, which they must starting in October 2025.

Electronic Submissions
• Source: Shutterstock

The Food and Drug Administration has published a final guidance document to help sponsors prepare to submit de novo requests electronically. The document, “Electronic Submission Template for Medical Device De Novo Requests,” describes the technical standards associated with preparation of the electronic submission template, or eSTAR, for de novo classification requests solely in electronic format.

“The electronic submission template includes the information and guided prompts FDA believes will best facilitate the collection and assembly of the necessary

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Regulation

More from Policy & Regulation